featured news

Medicare Fraud Case Takes Aim at Unnecessary Prescriptions of Dangerous Drug Clozapine

In a case involving Teva Pharmaceuticals USA, LLC, the Department of Justice recently settled hundreds of allegations of Medicare and Medicaid fraud relating to the improper recommendation of the generic drug clozapine – considered a drug of last resort for the treatment of schizophrenia. According to allegations, Teva, through its […]

Pittsburgh-Area West Penn Allegheny Health System Settles False Claims Act Case

In a recent settlement involving the False Claims Act’s anti-kickback provisions and the federal Stark Law, Pittsburgh’s West Penn Allegheny Health System has agreed to pay $1.5 million to settle claims it engaged in an unlawful exchange of benefits with Pittsburgh-area doctors and facilities. The case was handled by the […]

The SEC Files Brief in Support of Whistleblower in Case Against Siemens

In 2010, the Dodd Frank Act was enacted to further financial reform and bring about greater integrity from those working on Wall Street. One of the hallmark features of the Act involves the implementation of a whistleblower program designed to incentivize those with original information about securities fraud to come […]

False Claims Act Settlement Against Lantheus Medical Imaging & Bristol-Myers Squibb

The federal False Claims Act has proven to be so effective in combating healthcare, defense, and other types of fraud against the government that the majority of U.S. states have enacted similar statutes to address fraud within their own borders. In New York, the False Claims Act expressly includes acts […]

Securities and Exchange Commission Joins False Claims Act Investigation Against KBR

Over the past year, we have examined a False Claims Act case against one of the largest military contractors in the world: Kellogg, Brown & Root. Known as KBR, this firm has been awarded over $40 billion in government work throughout the Iraq and Afghanistan wars, primarily for logistical support. […]